Clinical trials
Recruiting Cardiomyopathy, Hypertrophic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Braveheart Bio, Inc. | 1 |
| Christopher Kramer | 1 |
| Columbia University | 1 |
| Imbria Pharmaceuticals, Inc. | 1 |
| Indiana University | 1 |
| Lexeo Therapeutics | 1 |
| Michael Ayers | 1 |
| Montefiore Medical Center | 1 |
| Oregon Health and Science University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 17 |
| Cardiomyopathies | 5 |
| Heart Failure | 4 |
| Amyloid Neuropathies, Familial | 2 |
| Arrhythmogenic Right Ventricular Dysplasia | 2 |
| Cardiomyopathy, Dilated | 2 |
| Cardiovascular Diseases | 2 |
| Heart Diseases | 2 |
| Hypertrophy, Left Ventricular | 2 |
| Aortic Valve Stenosis | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.